Reactivation of super-enhancers by KLF4 in human Head and Neck Squamous Cell Carcinoma

被引:21
|
作者
Tsompana, Maria [1 ]
Gluck, Christian [1 ]
Sethi, Isha [1 ]
Joshi, Ishita [1 ]
Bard, Jonathan [1 ]
Nowak, Norma J. [1 ]
Sinha, Satrajit [1 ]
Buck, Michael J. [1 ]
机构
[1] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Dept Biochem, Buffalo, NY 14260 USA
关键词
PLURIPOTENT STEM-CELLS; CHIP-SEQ; GENOMIC CHARACTERIZATION; HOMEOBOX GENES; HOX GENES; EXPRESSION; CANCER; TRANSCRIPTION; P63; DISCOVERY;
D O I
10.1038/s41388-019-0990-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Head and neck squamous cell carcinoma (HNSCC) is a disease of significant morbidity and mortality and rarely diagnosed in early stages. Despite extensive genetic and genomic characterization, targeted therapeutics and diagnostic markers of HNSCC are lacking due to the inherent heterogeneity and complexity of the disease. Herein, we have generated the global histone mark based epigenomic and transcriptomic cartogram of SCC25, a representative cell type of mesenchymal HNSCC and its normal oral keratinocyte counterpart. Examination of genomic regions marked by differential chromatin states and associated with misregulated gene expression led us to identify SCC25 enriched regulatory sequences and transcription factors (TF) motifs. These findings were further strengthened by ATAC-seq based open chromatin and TF footprint analysis which unearthed Kruppel-like Factor 4 (KLF4) as a potential key regulator of the SCC25 cistrome. We reaffirm the results obtained from in silico and chromatin studies in SCC25 by ChIP-seq of KLF4 and identify Delta Np63 as a co-oncogenic driver of the cancer-specific gene expression milieu. Taken together, our results lead us to propose a model where elevated KLF4 levels sustains the oncogenic state of HNSCC by reactivating repressed chromatin domains at key downstream genes, often by targeting super-enhancers.
引用
收藏
页码:262 / 277
页数:16
相关论文
共 50 条
  • [41] Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma
    Mark A Pershouse
    Adel K El-Naggar
    Kenneth Hurr
    Huai Lin
    WK Alfred Yung
    Peter A Steck
    Oncogene, 1997, 14 : 369 - 373
  • [42] ErbB4 expression in squamous cell carcinoma of the head and neck
    Ben-Yosef, Rami
    Marmor, Sylvia
    Starr, Alex
    Matceyevsky, Diana
    Khafif, Avi
    Vexler, Akiva
    TARGETED ONCOLOGY, 2006, 1 (04) : 181 - 185
  • [43] Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma
    Pershouse, MA
    ElNaggar, AK
    Hurr, K
    Lin, H
    Yung, WKA
    Steck, PA
    ONCOGENE, 1997, 14 (03) : 369 - 373
  • [44] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [45] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [47] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [48] Docetaxel and squamous cell carcinoma of the head and neck
    Calais, G
    BULLETIN DU CANCER, 2004, 91 (02) : 167 - 171
  • [49] Head and neck squamous cell carcinoma in childhood
    de Carvalho, MB
    Sobrinho, JD
    Rapoport, A
    Fava, AS
    Mendes, AF
    Kanda, JL
    Lehn, CN
    Chacra, J
    Menezes, MB
    Walder, F
    Franzi, SA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (02): : 96 - 99
  • [50] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81